Nature Cardiovascular Research Submission Guide
A source-checked guide to Nature Cardiovascular Research fit, article type, claim-to-evidence design, clinical reporting, and submission readiness.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
Quick answer: Submit to Nature Cardiovascular Research when the paper delivers an important advance in cardiac, vascular, or blood biology and the central claim is supported across the evidence layers it requires. A cardiovascular disease label, large cohort, or technically advanced model is not enough if the study does not change biological understanding, translational reasoning, clinical interpretation, or public-health action.
Use this Nature Cardiovascular Research submission guide to align scope, content type, claim breadth, reporting, data and code expectations, and the initial upload package before opening the submission system.
Nature Portfolio publishes Nature Cardiovascular Research as a dedicated cardiovascular and blood-biology journal. This owner is distinct from a generic Nature submission guide and from neighboring clinical or specialist cardiovascular titles.
The journal spans fundamental, translational, clinical, and public-health research. That range makes category clarity essential. A molecular mechanism, therapeutic study, population analysis, and resource paper each carry a different burden of proof; they should not be framed as versions of the same article.
Evidence basis: We checked the current submission guidelines, content-type definitions, journal information and scope, and editorial policies on August 19, 2026. Journal facts are sourced. The readiness tests below are Manusights editorial judgment.
Source limitation: Public pages define policy and preparation but do not reveal private editorial thresholds. This guide cannot predict an editorial decision or acceptance. Recheck every reporting form and file requirement in the live workflow.
Stop signal: Pause if the cardiovascular consequence is asserted rather than demonstrated, or if the title, abstract, first figure, and reporting package tell materially different versions of the study.
From our manuscript review practice
A cardiovascular dataset does not create Nature Cardiovascular Research fit. The paper needs an important biological or clinical question, a decisive evidence chain, and a claim whose breadth matches the model and population.
Decision at a glance
Gate | Evidence to inspect | Hold when |
|---|---|---|
Cardiovascular ownership | The mechanism, disease process, intervention, resource, or population question is intrinsically cardiovascular | The cardiovascular system is only the dataset or validation context |
Importance | The result changes a consequential biological, translational, clinical, or public-health decision | The advance is technically strong but narrow or confirmatory |
Claim-to-model fit | The experimental model and population support the breadth of the headline claim | Cell, animal, retrospective, or single-site evidence is generalized without a bridge |
Decisive evidence | The main figure and key analyses distinguish the proposed explanation from serious alternatives | Several suggestive findings substitute for one resolved mechanism or decision |
Reporting and reuse | Ethics, design, statistics, data, code, and source-data plans match the study | Essential validation or reporting is deferred until after review |
Choose the article type by the evidence contract
The current content page lists primary formats including Article, Analysis, Letter, Brief Communication, Resource, and Technical Report. Choose by the manuscript's actual contribution rather than the shortest route to submission.
Type of contribution | Core promise | Readiness question |
|---|---|---|
Mechanistic study | A causal or explanatory advance in cardiovascular biology | Does the evidence connect perturbation, mechanism, phenotype, and boundary? |
Translational study | A credible bridge from biological insight toward intervention or stratification | Is the translational step demonstrated rather than implied? |
Clinical analysis | A reliable finding with consequences for patients or clinical reasoning | Are design, comparators, confounding, endpoints, and uncertainty strong enough for the claim? |
Resource or technical report | A reusable capability that enables consequential cardiovascular research | Is utility demonstrated across realistic users, datasets, or tasks? |
Population or public-health study | A robust estimate or mechanism with actionable population relevance | Do measurement, selection, heterogeneity, and transportability support the inference? |
Reviews, Perspectives, Comments, and some other formats may be commissioned or require editorial contact. Verify the current content page before preparing a non-primary submission.
Match claim breadth to the evidence ladder
Map every headline phrase to the evidence layer that supports it:
- Molecular mechanism: perturbation, rescue, specificity, temporal order, and competing pathway checks.
- Cellular or tissue consequence: relevant models, dose and timing, phenotype validity, and biological replication.
- Organism or disease relevance: model limitations, sex and age where relevant, physiology, and clinically meaningful endpoints.
- Human association: cohort definition, measurement quality, confounding, missingness, multiplicity, and external validation.
- Clinical usefulness: comparison with existing practice, calibration, decision consequence, safety, and prospective evidence where the claim requires it.
Do not let the abstract jump from an early evidence layer to a later claim. A strong mechanistic paper can remain mechanistic; it does not need to promise immediate clinical impact.
Build the first-figure argument
Nature Portfolio editors and broad readers need to understand the question and consequence quickly. Treat the title, abstract, opening paragraphs, and first figure as one orientation system.
The first figure should establish the biological or clinical problem and the decisive pattern, not merely display study logistics. Its caption and surrounding text should state what is measured, what comparison matters, what uncertainty remains, and why the result changes the next experiment or decision.
First-screen element | It should answer | Warning sign |
|---|---|---|
Title | What cardiovascular advance occurred? | Technique and disease name without a finding |
Abstract opening | Why is the problem consequential? | Generic burden-of-disease background |
Main result | What was learned and under what boundary? | Several findings with no hierarchy |
First figure | What evidence makes the claim credible? | A workflow diagram that postpones all results |
Worked example: a vascular inflammation target
If the claim still outruns the evidence ladder, run a free Nature Cardiovascular Research readiness scan before assembling the files. Use it to find the weakest bridge, not to turn association into clinical utility.
Suppose a study identifies a protein associated with vascular inflammation in a mouse model and patient samples. A weak submission calls the protein a therapeutic target because its expression correlates with disease and knockout mice show less inflammation.
A stronger paper separates the steps. It identifies the relevant cell population, tests temporal and pathway specificity, performs rescue or orthogonal perturbation, and shows which vascular phenotype changes. Human evidence is used to test concordance and boundary rather than to claim treatment efficacy. The discussion distinguishes a validated disease mechanism from a clinically ready target. The evidence ladder and claim now match.
Prepare reporting before the portal
The journal's policies point life-science and clinical submissions toward Nature Portfolio reporting requirements. Depending on the work, authors may need a reporting summary, clinical registration and reporting information, ethics and consent statements, data and code availability, source data, competing interests, author contributions, and discipline-specific checklists.
Create a claim ledger before upload:
Claim | Supporting figure or table | Required reporting | Remaining limitation |
|---|---|---|---|
Central mechanism | Perturbation plus rescue | Design, replication, exclusions, statistics | Model or tissue boundary |
Translational relevance | Human or clinically relevant validation | Cohort, ethics, endpoints, uncertainty | No prospective intervention evidence |
Reusable resource | Benchmark and external use case | Data, code, version, access | Performance outside tested settings |
This prevents the abstract from outrunning the source data and exposes missing documentation before editorial assessment.
Failure patterns to repair
When we assess a cardiovascular manuscript for this journal, we compare the abstract, first figure, model choice, decisive experiment, human bridge, and limitation paragraph as one claim system.
Disease relevance is treated as mechanistic proof. A signal appears in a cardiovascular condition but the causal role is not distinguished. Narrow the claim or add evidence that separates mechanism from association.
Translation is declared, not demonstrated. Patient samples or a familiar drug are added after the mechanism. State the precise translational decision and show which evidence changes it.
The model boundary disappears. Findings from one cell system, animal model, ancestry group, or care setting become universal in the title and abstract. Restore the boundary where readers make the first interpretation.
The evidence package has many parts but no decisive test. Prioritize the experiment or analysis that rules out the strongest alternative. More panels do not automatically create a stronger argument.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
Prepare the current package
The current submission page asks authors to confirm journal fit, choose a supported content type, review editorial policies, and understand publishing options before uploading. Initial preparation includes a complete manuscript, figures and supporting material, readable language, and the files needed for the chosen peer-review model. A double-anonymized review option is available when its specific requirements are followed.
If the paper reaches acceptance in principle, the journal requests detailed formatting, reporting, data, code, source-data, and production files. Planning those materials before initial submission reduces the risk that a central result cannot be documented later.
Enter through the live Nature Cardiovascular Research submission page or its linked manuscript tracking system, and inspect every converted file.
Required package audit
- Complete manuscript: include the title, abstract, main text, methods, references, and content needed for editorial assessment.
- Figures and source data: keep labels readable and ensure the source-data route supports every central display.
- Supplementary information: cite each file and avoid moving a claim-critical control out of the main argument.
- Data availability and code statement: make repository links, access conditions, and legitimate restrictions internally consistent.
- Ethics approval and consent statements: match the study design, population, and current reporting policy.
- Funding, author contributions, and conflicts of interest: reconcile manuscript declarations with portal responses.
The current initial-formatting page permits PDF, Word, or TeX/LaTeX and requires no special initial styling. It gives no fixed main-text word limit and no fixed figure limit for that initial package; the selected content-type page still controls format-specific bounds.
Author tracking timeline based on the published process
Nature describes the sequence but does not promise a case-specific duration. The markers below are author checkpoints; Day 0 is literal, while later labels are not service-level commitments.
- Day 0: upload through the manuscript tracking system, inspect the proof, and preserve the submitted files.
- Day 1 onward: the editorial assistant checks quality and completeness; resolve a technical request without changing unflagged content.
- Week 1 onward: an editor and editorial team assess whether the work should enter external review, with no public deadline promised here.
- Later weeks: if reviewers are invited, track reports and revisions against the original claim-evidence map rather than treating elapsed time as a verdict.
Final checklist
- Name the cardiovascular question and consequence without relying on prestige language.
- Choose the content type that matches the contribution and evidence contract.
- Map each claim to the model, population, figure, and reporting requirement that supports it.
- Keep the title and abstract inside the strongest demonstrated evidence layer.
- Make the first figure information-bearing and interpretable to an adjacent specialist.
- Distinguish mechanism, translation, clinical utility, and public-health relevance.
- Prepare ethics, consent, registration, data, code, source-data, and competing-interest materials.
- Follow the chosen anonymity route across manuscript, files, metadata, and links.
- Recheck the live journal guidance and inspect the submission proof.
Common questions
These answers cover recurring preparation decisions, while the live journal content, policy, and submission pages remain the authority for current article-type and file requirements.
What research fits Nature Cardiovascular Research?
The scope spans cardiac, vascular, and blood biology across fundamental, translational, clinical, and public-health research. The paper still needs an important cardiovascular advance with a matching evidence chain.
What content types can authors submit?
The current page includes Article, Analysis, Letter, Brief Communication, Resource, and Technical Report among primary formats, plus non-primary formats with different routes. Confirm the live definition before choosing.
Is double-anonymized review available?
Yes. The current preparation flow offers the option. Audit the manuscript, file metadata, acknowledgments, self-citations, and repository links together rather than removing names alone.
Where are manuscripts submitted?
Use the submission link on the current journal-guidelines page so that the destination and checklist are current. Confirm the journal, article type, review model, and required files before upload.
What to read next
Compare the Circulation submission guide, Circulation Research submission guide, European Heart Journal submission guide, and Nature Medicine submission guide. Browse the journal guide library for another owner, or use a free manuscript readiness scan to test claim breadth, evidence, reporting, and package continuity.
Official sources accessed 2026-08-19.
- Nature Cardiovascular Research submission guidelines, Nature Portfolio.
- Initial-submission formatting, Nature Portfolio.
- Editorial process and peer review, Nature Portfolio.
- Nature Cardiovascular Research content types, Nature Portfolio.
- Journal information, Nature Portfolio.
- Editorial policies, Nature Portfolio.
Submit If
Submit when the cardiovascular advance is important, the decisive evidence resolves the main alternative, and the claim remains honest about model, population, and translational boundaries.
Think Twice If
- The manuscript is technically advanced, but cardiovascular relevance is only the application setting.
- An association, animal phenotype, or retrospective model is framed as clinical utility.
- The first figure explains the workflow but not the finding.
- A broad title depends on one model, site, ancestry group, or narrow endpoint.
- Essential reporting, source data, or code cannot support the paper's central claim.
Frequently asked questions
The journal covers important advances across cardiac, vascular, and blood biology, including fundamental, translational, clinical, and public-health research. The manuscript still needs a clear cardiovascular question and a consequential advance.
The current content page lists Article, Analysis, Letter, Brief Communication, Resource, Technical Report, and several invited or non-primary formats. Confirm the exact definition and whether prior editorial contact is expected before choosing a type.
The current preparation guidance offers a double-anonymized peer-review option. Authors choosing it must follow the live anonymization instructions for the manuscript and related files.
The journal's current submission-guidelines page links to its online manuscript system. Always enter through the live journal page so the route and required files are current.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Your manuscript is never used to train any model.